Source: QGel Vimeo Channel

QGel posted a video "'Organoid technology' poised to transform cancer care" on VIMEO

Cast: QGel

QGel's Competitors | QGel's News | QGel's Financials

Followers on Owler

11

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Colin Sanctuary's photo - Co-Founder & CEO of QGel

Co-Founder & CEO

Colin Sanctuary

CEO Approval Rating

68/100

QGel develops and commercializes extracellular matrices for the treatment of cancer.